Infertility Services Market in US 2017-2021

February 17, 2017
SKU:
IRTNTR12046
This market research identifies CARE facility, CooperSurgical, Ferring Pharmaceuticals, Monash IVF, Merck, and Vitrolife as the key vendors in the infertility services market in the US. This report also presents a detailed segmentation of the market by underlying cause (male infertility and female fertility) and services (ART services and infertility drug services).

Overview of the infertility services market in the US

Technavio’s market research analyst predicts that the infertility services market in the US will post an astounding CAGR growth of nearly 5% during the forecast period. One of the primary factors driving this market’s growth is the increasing success rate of infertility treatments. Success rates have become better over the past ten years as most of the fertility and infertility drugs have drastically improved the success rates of live births. These services help women assist women whose infertility is due to issues like ovulation. Moreover, these services also assist in correcting physiological complications that prevent the eggs from fertilizing and forming the embryo that implants onto the uterine wall. The success rate of these treatments is garnering interest in future consumers and existing ones and ensuring growth by word of mouth marketing.

One of the latest trends that will gain traction in the infertility services market in US is the high investments in the R&D. The vendors in the market are extensively researching and developing innovative technologies related to infertility services. Major research studies like understanding the effects of gynecologic ailments such as tubal disease and PCOS on fertility rates helps pick the right infertility treatments. Furthermore, utilization of knowledge from the basic stem cell research to know about the reproductive processes and develop novel therapeutics for treating infertility. Besides enhancing detection methods of abnormalities in preimplantation embryos and developing enhanced technologies, understanding the lasting effects of ART interventions on parental and child health help infertility clinics offer better support and treatment for infertility.

Competitive landscape and key vendors

The largely fragmented fertility services market in the US has numerous global and local vendors with consolidation and industrialization to raise their market share. Mergers and acquisitions assist them in extending their product ranges and widen geographical presence. Large investments are being done in R&D to come up with advanced products and gain technological leverage over the competitors. The market has tremendous growth potential for revenue generation and the entry of new players.

Some of the key vendors in the market are:

  • CARE facility
  • CooperSurgical
  • Ferring Pharmaceuticals
  • Monash IVF
  • Merck
  • Vitrolife

Other prominent vendors include AbbVie, Apricus Biosciences, AstraZeneca, Auxogyn, Eli Lilly, EMD Serono, IKS International, InVitro Care, INVO Bioscience, Irvine Scientific, LifeGlobal, MedITEX, NMC Health, OB GYN Associates, OvaScience, Pantec Biosolutions, Reproductive Medicine Associates of New Jersey, The Sims Clinic, TriHealth, Virtus Health, and Xytex Cryo International.

Segmentation by underlying cause and analysis of the infertility services market in the US

  • Male infertility
  • Female infertility

Male infertility segment is one of the fastest growing segments in this market. It can be caused by a range of problems such as hormonal disturbances, psychological problems, and physical complications. There are many successful treatment choices to opt for though there are limited able medicines to treat male infertility. Pre-vascular factors, hypogonadism, cryptorchidism, and many more are the some of the causes of male infertility. Male infertility can be treated with hormonal treatments, such as dopamine agonists that help in treating low testosterone, hypogonadotropic hypogonadism, and hyperprolactinemia. Surgical treatments are done on an outpatient basis and include varicocele surgery, microsurgical epididymal sperm aspiration for treating infertility caused by blockage, and testicular sperm extraction.

Segmentation by services and analysis of the infertility services market in US

  • ART services
  • Infertility drug services

During 2016, majority of the market share was held by ART services segment and is expected to dominate the market over the next four years. The growth of this segment is attributed to the high success rates of this treatment. IVF is the most popular treatment for infertility, accounting for more than 99% of all ART treatments. Advances in technology related to assisted reproduction are enabling couples to select embryos and have offspring with genes that are closer to their parents, which will boost this segment’s growth until the end of 2021.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2021?
  • What are the key factors driving the infertility services market in the US?
  • What are the key market trends impacting the growth of the infertility services market in the US?
  • What are the challenges to market growth?
  • Who are the key vendors in the infertility services market in the US?
  • What are the market opportunities and threats faced by the vendors in the infertility services market in the US?
  • What are the key outcomes of the five forces analysis of the infertility services market in the US?

Related reports